BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 15163705)

  • 1. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.
    Han Y; Lassen K; Monie D; Sedaghat AR; Shimoji S; Liu X; Pierson TC; Margolick JB; Siliciano RF; Siliciano JD
    J Virol; 2004 Jun; 78(12):6122-33. PubMed ID: 15163705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy.
    Ikeda T; Shibata J; Yoshimura K; Koito A; Matsushita S
    J Infect Dis; 2007 Mar; 195(5):716-25. PubMed ID: 17262715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.
    Hermankova M; Siliciano JD; Zhou Y; Monie D; Chadwick K; Margolick JB; Quinn TC; Siliciano RF
    J Virol; 2003 Jul; 77(13):7383-92. PubMed ID: 12805437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo.
    Lassen KG; Bailey JR; Siliciano RF
    J Virol; 2004 Sep; 78(17):9105-14. PubMed ID: 15308706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.
    Kieffer TL; Kwon P; Nettles RE; Han Y; Ray SC; Siliciano RF
    J Virol; 2005 Feb; 79(3):1975-80. PubMed ID: 15650227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells.
    Zhou Y; Zhang H; Siliciano JD; Siliciano RF
    J Virol; 2005 Feb; 79(4):2199-210. PubMed ID: 15681422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multifactorial nature of HIV-1 latency.
    Lassen K; Han Y; Zhou Y; Siliciano J; Siliciano RF
    Trends Mol Med; 2004 Nov; 10(11):525-31. PubMed ID: 15519278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.
    Monie D; Simmons RP; Nettles RE; Kieffer TL; Zhou Y; Zhang H; Karmon S; Ingersoll R; Chadwick K; Zhang H; Margolick JB; Quinn TC; Ray SC; Wind-Rotolo M; Miller M; Persaud D; Siliciano RF
    J Virol; 2005 Apr; 79(8):5185-202. PubMed ID: 15795302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.
    Spina CA; Guatelli JC; Richman DD
    J Virol; 1995 May; 69(5):2977-88. PubMed ID: 7707524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.
    Bailey JR; Sedaghat AR; Kieffer T; Brennan T; Lee PK; Wind-Rotolo M; Haggerty CM; Kamireddi AR; Liu Y; Lee J; Persaud D; Gallant JE; Cofrancesco J; Quinn TC; Wilke CO; Ray SC; Siliciano JD; Nettles RE; Siliciano RF
    J Virol; 2006 Jul; 80(13):6441-57. PubMed ID: 16775332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection.
    Pierson TC; Zhou Y; Kieffer TL; Ruff CT; Buck C; Siliciano RF
    J Virol; 2002 Sep; 76(17):8518-31. PubMed ID: 12163571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli.
    Swiggard WJ; Baytop C; Yu JJ; Dai J; Li C; Schretzenmair R; Theodosopoulos T; O'Doherty U
    J Virol; 2005 Nov; 79(22):14179-88. PubMed ID: 16254353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals.
    Fondere JM; Petitjean G; Huguet MF; Salhi SL; Baillat V; Macura-Biegun A; Becquart P; Reynes J; Vendrell JP
    J Virol; 2004 Oct; 78(19):10536-42. PubMed ID: 15367620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells.
    Plesa G; Dai J; Baytop C; Riley JL; June CH; O'Doherty U
    J Virol; 2007 Dec; 81(24):13938-42. PubMed ID: 17928354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.
    Chun TW; Justement JS; Lempicki RA; Yang J; Dennis G; Hallahan CW; Sanford C; Pandya P; Liu S; McLaughlin M; Ehler LA; Moir S; Fauci AS
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1908-13. PubMed ID: 12552096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
    Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
    J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.
    Lassen KG; Ramyar KX; Bailey JR; Zhou Y; Siliciano RF
    PLoS Pathog; 2006 Jul; 2(7):e68. PubMed ID: 16839202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.
    Biancotto A; Grivel JC; Gondois-Rey F; Bettendroffer L; Vigne R; Brown S; Margolis LB; Hirsch I
    J Virol; 2004 Oct; 78(19):10507-15. PubMed ID: 15367617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model.
    Shan L; Yang HC; Rabi SA; Bravo HC; Shroff NS; Irizarry RA; Zhang H; Margolick JB; Siliciano JD; Siliciano RF
    J Virol; 2011 Jun; 85(11):5384-93. PubMed ID: 21430059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.
    Chun TW; Finzi D; Margolick J; Chadwick K; Schwartz D; Siliciano RF
    Nat Med; 1995 Dec; 1(12):1284-90. PubMed ID: 7489410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.